PhRMA’s “Reality Check”
Executive Summary
Pharmaceutical Research & Manufacturers of America President Alan Holmer is embarking on a 45-city media tour as part of the trade association's effort "to ramp up the public relations effort of the pharmaceutical industry." The first stop is two days in Tampa that include four speeches, three radio interviews and two editorial board meetings along with other press events. The "Reality Check" tour will "set the record straight" about the value of pharmaceuticals, PhRMA declares. The association board approved the more aggressive media outreach campaign in November (1"The Pink Sheet" Dec. 16, 2002, p. 20)...
You may also be interested in...
PhRMA Vows To “Re-Shape” Policy Debate; Will Reach Out To Critics
The Pharmaceutical Research & Manufacturers of America plans to make peace overtures to some of its critics within the healthcare sector as part of a new image strategy heading into 2003
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.